Cat.#: ACPP-1069
| Despition | Calretinin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1147 | Recombinant Human NRP2 Protein (6×His Tag) (AC1147) | 50 µg | inquiry |
| ACPP-1052 | Recombinant Human PGRPS Protein (Fc Tag) (AC1052) | 50 µg | inquiry |
| ACPP-1015 | Recombinant Human ROR1 Protein (Fc Tag) (AC1015) | 50 µg | inquiry |
| ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg | inquiry |
| ACPP-1601 | Rat ACRP30 Protein (AC1601) | 2 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1795 | Human STXBP6 Protein (AC1795) | 5 µg | inquiry |
| ACPP-1848 | Human MTPN Protein (AC1848) | 5 µg | inquiry |
| ACPP-1096 | Synthetic Nanodisc Human CXCR4 Protein (AC1096) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.